Pulmonary Program
The Pediatric Pulmonary Program offers the most advanced diagnostic and treatment capabilities to evaluate infants, children and adolescents with acute and chronic lung disorders.
Pediatric flexible fiberoptic bronchoscopy can be used as a diagnostic or therapeutic tool in the treatment of pediatric lung disorders, and state-of-the-art pulmonary function testing, including asthma challenge testing and exercise challenge, is available through the Pulmonary Program.
The program provides treatment for such clinical conditions as asthma, chronic cough, chronic lung disease of prematurity, airway abnormalities and chest wall deformities.
The program’s Comprehensive Cystic Fibrosis Center is the oldest and largest of the centers in New Jersey, offering patient care, teaching and research. The center — which includes both pediatric and adult programs — is accredited by the National Cystic Fibrosis Foundation and is designated by the State of New Jersey as a referral center for Cystic Fibrosis Newborn Screening.
Patient care is provided by a multidisciplinary team of specialists trained in cystic fibrosis care. Monmouth’s Cystic Fibrosis Center has been designated as a Therapeutic Development Center by the Cystic Fibrosis Foundation's Therapeutic Development Network. Clinical trials of new therapies for cystic fibrosis are offered as a result of the center being a part of the Cystic Fibrosis Foundation's Research Network. A team of trained research clinicians oversee the multiple trials offered at Monmouth's Cystic Fibrosis Center.